University of Texas Health Science Center San Antonio at the Cancer Therapy and Research Center

San Antonio, Texas 78229

2 studies enrolling now · 4 studies all time

What they study most

Astrocytoma, Diffuse Large B-cell Lymphoma, Glioblastoma, Recurrent Glioblastoma

Studies at this site

• Loncastuximab and Roflumilast Added to R-CHOP (Lo-(Rituximab and Roflumilast) RR-CHOP) for Naïve High-Risk Diffuse Large B-cell Lymphoma (DLBCL) — Recruiting now
• Sacituzumab Govitecan in Recurrent Glioblastoma — Recruiting now
• TVB- 2640 in Combination With Bevacizumab in Patients With First Relapse of High Grade Astrocytoma — Completed
• TH-302 in Combination With Bevacizumab for Glioblastoma — Completed